Strokes and holes and headaches: Are they a package deal?

Lancet

Volumn 364, Issue 9448, 2004, Pages 1840-1842

  Holmes Jr , David R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; WARFARIN;

ARTERY CATHETER; ARTIFICIAL EMBOLISM; CLINICAL RESEARCH; COLOR ULTRASOUND FLOWMETRY; DIAGNOSTIC IMAGING; HEADACHE; HEART ATRIUM SEPTUM DEFECT; HUMAN; MIGRAINE; NERVE CELL EXCITABILITY; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 8844249440     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17457-6     Document Type: Note

References (16)

1. Holmes DR Jr, Cohen H, Katz WE, Reeder GS. Patent Foramen Ovale, Systemic Embolization and Closure. Curr Probl Cardiol. 29:2004;49-96
2. Cohnheim J. Thrombose und Embolie: Vorlesung Uber allgemeine. Pathologie. Berlin, Germany: Hirschwald; 1877: 134.
3. Zahn FW. Thrombose de plusieurs branches, de la veine cave inferieure avec embolies consecutives das les arteres pulmonair, splenique, renale et iliaque droite. Rev med Suisse Romande. 1:1881;227-237
4. Fabricius AM, Kruger M, Hanke M, Mohr FW. Caught in the act: impending paradoxical embolism. Asian Cardiovasc Thorac Ann. 10:2002;342-343
5. Brandt RR, Neumann T, Neuzner J, Rau M, Faunde I, Hamm CW. Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: no evidence for thrombus deposition with antiplatelet agents. J Am Soc Echocardiogr. 15:2002;1094-1098
6. Bruch L, Parsi A, Grad MO, et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation. 105:2002;2845-2848
7. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 55:2000;1172-1179
8. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 345:2001;1740-1746
9. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attach. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J. 130:1995;1083-1088
10. Dearani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation. 100:(suppl 19):1999;I171-I175
11. Del Sette M, Angeli S, Leandri M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis. 8:1998;327-330
12. Wilmhurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond). 100:2001;215-220
13. Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis. 13:2002;102-106
14. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 356:2000;1648-1651
15. Schwerzmann M, Wiher S, Nedeltchev K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology. 62:2004;1399-1401
16. Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence on migraine. Neurology. 62:2004;1439-1440